Federation des caisses Desjardins du Quebec’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.6M Buy
998,249
+337,704
+51% +$27M 0.23% 74
2025
Q4
$63M Buy
660,545
+462,046
+233% +$45.3M 0.24% 72
2025
Q3
$19.4M Sell
198,499
-2,467
-1% -$255K 0.08% 188
2025
Q2
$21.6M Buy
200,966
+28,297
+16% +$2.86M 0.09% 159
2025
Q1
$17.4M Buy
172,669
+1,264
+0.7% +$127K 0.09% 164
2024
Q4
$15.3M Sell
171,405
-4,497
-3% -$396K 0.08% 183
2024
Q3
$14.7M Buy
175,902
+59,354
+51% +$4.68M 0.07% 185
2024
Q2
$8.98M Sell
116,548
-6,624
-5% -$485K 0.05% 215
2024
Q1
$8.37M Buy
123,172
+66,237
+116% +$4.26M 0.06% 219
2023
Q4
$3.29M Buy
56,935
+1,879
+3% +$100K 0.03% 333
2023
Q3
$2.91M Sell
55,056
-693
-1% -$36.3K 0.03% 345
2023
Q2
$3.02M Buy
55,749
+4,854
+10% +$254K 0.03% 362
2023
Q1
$2.55M Sell
50,895
-7,912
-13% -$373K 0.03% 352
2022
Q4
$2.72M Sell
58,807
-324
-0.5% -$14K 0.03% 318
2022
Q3
$2.29M Sell
59,131
-1,744
-3% -$70K 0.03% 361
2022
Q2
$2.27M Sell
60,875
-6,900
-10% -$281K 0.03% 368
2022
Q1
$3M Sell
67,775
-79,862
-54% -$3.46M 0.03% 348
2021
Q4
$6.27M Sell
147,637
-5,953
-4% -$250K 0.06% 229
2021
Q3
$6.66M Buy
153,590
+1,122
+0.7% +$49.6K 0.07% 221
2021
Q2
$6.52M Buy
152,468
+15,023
+11% +$632K 0.07% 231
2021
Q1
$5.31M Sell
137,445
-11,783
-8% -$446K 0.06% 248
2020
Q4
$5.36M Buy
149,228
+14,719
+11% +$530K 0.06% 247
2020
Q3
$5.14M Buy
134,509
+85,111
+172% +$3.28M 0.07% 222
2020
Q2
$1.73M Buy
49,398
+867
+2% +$31.2K 0.03% 417
2020
Q1
$1.58M Buy
48,531
+13,752
+40% +$537K 0.03% 403
2019
Q4
$1.57M Buy
34,779
+502
+1% +$21K 0.02% 518
2019
Q3
$1.39M Sell
34,277
-426
-1% -$18K 0.02% 541
2019
Q2
$1.49M Buy
34,703
+32,784
+1,708% +$1.26M 0.02% 515
2019
Q1
$73.7K Sell
1,919
-1,300
-40% -$49.7K ﹤0.01% 1225
2018
Q4
$114K Buy
3,219
+1,444
+81% +$52.4K ﹤0.01% 1105
2018
Q3
$68.3K Hold
1,775
﹤0.01% 1269
2018
Q2
$58K Sell
1,775
-117
-6% -$3.53K ﹤0.01% 1315
2018
Q1
$51.7K Sell
1,892
-280
-13% -$7.61K ﹤0.01% 1321
2017
Q4
$53.8K Buy
2,172
+137
+7% +$3.78K ﹤0.01% 1320
2017
Q3
$59.4K Sell
2,035
-340
-14% -$9.39K ﹤0.01% 1280
2017
Q2
$65.8K Sell
2,375
-945
-28% -$25.1K ﹤0.01% 1323
2017
Q1
$82.6K Buy
+3,320
New +$80.7K ﹤0.01% 1062

Other funds holding BSX

Federation des caisses Desjardins du Quebec's BSX Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its Boston Scientific (BSX) stake by 51% in Q1 2026, buying an estimated $27M and bringing the position to 998,249 shares worth $62.6M. The position accounts for 0.23% of the portfolio, ranked #74.

Federation des caisses Desjardins du Quebec first reported a position in BSX in Q1 2017 and has held it in 37 quarters since. The position peaked at $63M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 998,249 shares of Boston Scientific worth $62.6M as of Q1 2026.
  • Federation des caisses Desjardins du Quebec bought 337,704 Boston Scientific shares in Q1 2026, an estimated $27M.
  • Boston Scientific made up 0.23% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #74 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Boston Scientific in Q1 2017 and has held it in 37 quarters since.
  • Federation des caisses Desjardins du Quebec's Boston Scientific position peaked at $63M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.